Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India

This open-label study assessed the safety and immunogenicity of two doses (14 days apart) of an indigenously manufactured, killed, bivalent (Vibrio cholerae O1 and O139), whole-cell oral cholera vaccine (SHANCHOL; Shantha Biotechnics) in healthy adults (n = 100) and children (n = 100) in a cholera e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Raghava Mohan, Venkata, Raj, Santosh, Dhingra, Mandeep Singh, Aloysia D’Cor, Naveena, Singh, Ajit Pal, Saluja, Tarun, Kim, Deok Ryun, Midde, Venkat Jayanth, Kim, Yanghee, Vemula, Sridhar, Narla, Santhosh Kumar, Sah, Binod, Ali, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581248/
https://ncbi.nlm.nih.gov/pubmed/31211792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0218033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados